Apogee Therapeutics, Inc. Gains 46.66%
Mon, Jun 22, 2026 at 07:36 PM
Apogee Therapeutics, Inc. (APGE:NASDAQ) shot up at $132.55, representing a gain of 46.7%. On Mon, Jun 22, 2026, APGE:NASDAQ touched a New 2-Week High of $132.55. The stock got featured on our News Catalysts scanner on Mon, Jun 22, 2026 at 01:52 PM in the 'ACQUISITION' category. From Mon, Jun 08, 2026, the stock recorded 55.56% Up Days and 30.00% Green Days
About Apogee Therapeutics, Inc. (APGE:NASDAQ)
Apogee Therapeutics, Inc.
Top 10 Gainers:
- Nexentis Technologies Inc Com Par $0.0001 (New) 2025 (NXTS:NASDAQ), 155.91%
- Eshallgo Inc. (EHGO:NASDAQ), 125.56%
- Aditxt, Inc. (ADTX:NASDAQ), 92%
- Getty Images Holdings, Inc. (GETY:NYSE), 90.05%
- Tenon Medical, Inc. (TNON:NASDAQ), 77.57%
- Sky Quarry Inc. (SKYQ:NASDAQ), 62.39%
- Definium Therapeutics Inc. (DFTX:NASDAQ), 49.8%
- Conduit Pharmaceuticals Inc. (CDT:NASDAQ), 47.06%
- Apogee Therapeutics, Inc. (APGE:NASDAQ), 46.66%
- FG Merger II Corp. (FGMC:NASDAQ), 44.56%